Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Breast Cancer ; : 233-243, 2018.
Artigo em Inglês | WPRIM | ID: wpr-716699

RESUMO

Breast cancer has the highest incidence among all malignancies diagnosed in women. Therapies have significantly improved over the years due to extensive molecular and clinical research; in a large number of cases, targeted therapies have provided better prognosis. However, one specific subtype remains elusive to targeted therapies–the triple-negative breast cancer. This immunohistochemically defined subtype is resistant to both endocrine and targeted therapies, leading to its poor prognosis. A field that is of great promise in current cancer research is epigenetics. By studying the epigenetic mechanisms underlying tumorigenesis–DNA methylation, histone modifications, and noncoding RNAs–advances in cancer treatment, diagnosis, and prevention are possible. This review aims to synthesize the epigenetic discoveries that have been made related to the triple-negative breast cancer.


Assuntos
Feminino , Humanos , Neoplasias da Mama , Mama , Diagnóstico , Metilação de DNA , Epigenômica , Código das Histonas , Incidência , Metilação , Prognóstico , RNA não Traduzido , Neoplasias de Mama Triplo Negativas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA